Conference Scene: Pharmacogenomics at the second PharmSciFair 2009: adverse drug reactions and clinical implementation | Zendy

Rianne MF van Schie | Zendy; Ingolf Cascorbi | Zendy; Anke H. Maitlandvan der Zee | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Conference Scene: Pharmacogenomics at the second PharmSciFair 2009: adverse drug reactions and clinical implementation

Author(s) -

Rianne MF van Schie,

Ingolf Cascorbi,

Anke H. Maitlandvan der Zee

Publication year - 2009

Publication title -

pharmacogenomics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.541

H-Index - 91

eISSN - 1744-8042

pISSN - 1462-2416

DOI - 10.2217/pgs.09.95

Subject(s) - pharmacogenomics , clinical trial , drug reaction , medicine , pharmacogenetics , relevance (law) , adverse effect , pharmacology , drug , political science , biology , biochemistry , genotype , law , gene

From 8th to 12th June 2009, the second PharmSciFair took place in Nice, France. Sessions were organized on different types of pharmaceutical research. Two pharmacogenomics sessions were organized by the European Federation for Pharmaceutical Sciences Network on Research in Pharmacogenetics/Pharmacogenomics. The topics of the sessions were adverse drug reactions and clinical implementation. Important conclusions of the presentations were that there has been much progress in the field of pharmacogenomics and that implementation in clinical practice is not as easy as it was once thought. Large prospective trials might be necessary to prove clinical relevance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research